Cost-utility of tiotropium in patients with severe asthma

Cost-utility of tiotropium in patients with severe asthma

Abstract Summary Add-on therapy with tiotropium was cost-effective when added to usual care in patients who remain uncontrolled despite treatment with medium or high-dose ICS/LABA in a middle-income country. Background A significant proportion of asthma patients remain uncontrolled despite inhaled c...

Full description

Bibliographic Details
Main Authors: Jefferson Antonio Buendía, Diana Guerrero Patiño
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Tiotropium
Uncontrolled asthma
Cost-effectiveness analysis
Decision analysis
Markov model
Online Access:https://doi.org/10.1186/s12962-023-00508-x

Internet

https://doi.org/10.1186/s12962-023-00508-x

Similar Items